CABG shows survival benefits in study of patients with diabetes, CAD

08/13/2013 | Healio

Data on 232 patients with diabetes and multivessel coronary artery disease indicated that those who underwent coronary artery bypass graft surgery had lower rates of cardiac and overall mortality at 10 years, compared with those who received medical therapy. Differences in mortality rates between percutaneous coronary intervention and both medical therapy and CABG were not statistically significant, researchers reported in the American Heart Journal.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC